VMP 42033111000001102

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Bicalutamide 150mg tablets
BNF code 0803042A0AAABAB
Virtual Therapeutic Moiety Bicalutamide
Date identifier became valid 7 Jul 2023
Previous product identifier 327368008
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Bicalutamide
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 150.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Bicalutamide 150mg tablets (A A H Pharmaceuticals Ltd)
Bicalutamide 150mg tablets (Accord-UK Ltd)
Bicalutamide 150mg tablets (Alliance Healthcare (Distribution) Ltd)
Bicalutamide 150mg tablets (Almus Pharmaceuticals Ltd)
Bicalutamide 150mg tablets (Bristol Laboratories Ltd)
Bicalutamide 150mg tablets (Crescent Pharma Ltd)
Bicalutamide 150mg tablets (Medihealth (Northern) Ltd)
Bicalutamide 150mg tablets (Morningside Healthcare Ltd)
Bicalutamide 150mg tablets (Phoenix Healthcare Distribution Ltd)
Bicalutamide 150mg tablets (Relonchem Ltd)
Bicalutamide 150mg tablets (Sigma Pharmaceuticals Plc)
Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)
Bicalutamide 150mg tablets (Teva UK Ltd)
Casodex 150mg tablets (AstraZeneca UK Ltd)
Casodex 150mg tablets (CST Pharma Ltd)
Virtual Medicinal Product Packs
Bicalutamide 150mg tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback